Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-7,047
Closed -$204K 236
2020
Q3
$204K Sell
7,047
-7,391
-51% -$232K 0.01% 218
2020
Q2
$513K Sell
14,438
-9,569
-40% -$403K 0.03% 151
2020
Q1
$1.24M Sell
24,007
-1,683
-7% -$80.9K 0.1% 90
2019
Q4
$1.75M Sell
25,690
-762
-3% -$47.8K 0.11% 87
2019
Q3
$1.27M Sell
26,452
-119,761
-82% -$6.25M 0.08% 99
2019
Q2
$9.76M Sell
146,213
-76,022
-34% -$5.79M 0.62% 52
2019
Q1
$21.2M Buy
222,235
+88,449
+66% +$11M 1.44% 32
2018
Q4
$16.6M Buy
133,786
+2,056
+2% +$339K 1.35% 36
2018
Q3
$32.2M Buy
131,730
+7,490
+6% +$1.73M 2.22% 13
2018
Q2
$23.1M Buy
124,240
+2,018
+2% +$336K 1.87% 23
2018
Q1
$15M Buy
+122,222
New +$14.9M 2% 21

Other funds holding INGN

Chicago Capital's INGN Position: Q4 2020 in Review

Chicago Capital sold out of Inogen (INGN) in Q4 2020, closing a stake of 7,047 shares — an estimated $204K sold.

Chicago Capital first reported a position in INGN in Q1 2018 and held it in 11 quarters. The position peaked at $32.2M in Q3 2018. 161 funds tracked by Wall St. Rank hold INGN as of Q4 2020.

  • Chicago Capital reported no remaining Inogen position as of Q4 2020 after selling out during the quarter.
  • Chicago Capital sold 7,047 Inogen shares in Q4 2020, an estimated $204K.
  • Chicago Capital first reported a position in Inogen in Q1 2018 and held it in 11 quarters.
  • Chicago Capital's Inogen position peaked at $32.2M in Q3 2018.
  • 161 funds tracked by Wall St. Rank held Inogen as of Q4 2020.

Based on Chicago Capital's 13F filing for Q4 2020, filed 25 Jan 2021.